XML 33 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaborative Research and Development Agreements (Tables)
3 Months Ended
Mar. 31, 2014
Agreement With Gsk
 
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under our agreement with GSK (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2014

 

 

2013

 

Initial payment

 

$

631

 

 

$

357

 

Total

 

$

631

 

 

$

357

 

 

Astra Zeneca
 
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2014

 

 

2013

 

Initial payment

 

$

180

 

 

$

180

 

Subsequent payment

 

 

675

 

 

 

-

 

Performance of research activities

 

 

887

 

 

 

346

 

Total

 

$

1,742

 

 

$

526

 

 

National Institutes of Health
 
Summary of Revenues Recognized by Major Customer

The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2014

 

 

2013

 

NIAID contracts

 

$

874

 

 

$

598

 

All other NIH contracts

 

 

251

 

 

 

162

 

Total grant revenue

 

$

1,125

 

 

$

760